Vaccine Adjuvants Market Overview, Growth, Trends, Analysis, Research Report (2020-2030)

Vaccine Adjuvants Market Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adjuvant Class (Mineral Salt Adjuvant, Emulsion Adjuvant, Liposome Adjuvant, and Others), Type (Human Vaccine Adjuvant and Veterinary Vaccine Adjuvant), and Geography

  • Report Code : TIPRE00004430
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 155
Buy Now

Vaccine Adjuvant Market Size and Regional Overview by 2030

Buy Now

The Vaccine Adjuvant market size is projected to grow from US$ 2,482.39 million in 2022 to US$ 6,931.55 million by 2030; the market is estimated to record a CAGR of 13.7% during 2022–2030. Technological advancements is likely to remain key trends in the market.

Vaccine Adjuvants Market Analysis

In 2020, NIAID established Vaccine Adjuvant Compendium (VAC) for the collaboration between broader scientific community and NIAID-supported vaccine adjuvant researchers. This network-based tool displays adjuvant characteristics to assist vaccine makers to identify suitable adjuvants for target disease.  Also, support various government authorities to foster vaccine adjuvant R&D, top manufacturers collaborations, and product launches through such business strategies are likely to provide profitable opportunities for the growth of the vaccine adjuvants market during the forecast period.

Vaccine Adjuvants Market Overview

Vaccine Adjuvant Technology encompasses nanotechnology, and its production includes supercritical, critical, or near-critical fluids with or without polar cosolvents such as ethanol [referred to as superfluids (SFS)]. Biodegradable biopolymers are dissolved in SFS and mixed with subunit vaccines in an aqueous solution or as a slurry of nanoparticles. Therefore, such new vaccine adjuvant technologies are being developed to make biodegradable polymer nanospheres (PNS) through novel processes, which allows vaccine manufacturers to rule out the use of organic solvents.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Vaccine Adjuvants Market: Strategic Insights

vaccine-adjuvants-market
Market Size Value inUS$ 2,482.39 million in 2022
Market Size Value byUS$ 6,931.55 million by 2030
Growth rateCAGR of 13.7% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Vaccine Adjuvants Market Drivers and Opportunities

Advantages of Vaccine Adjuvants to Favor Market

In recent years, adjuvant vaccines have been developed to enhance humoral and cell-mediated immune response after vaccination. By adding adjuvant components, vaccine efficacy is improved. The primary mechanisms of actions of the newer adjuvants involve enhancement of the innate immune system and lead to improved humoral and cell-mediated immunity against infections in populations.

Product Launches and Developments in Adjuvant Studies

Over past decades, non-biogenic adjuvants, biogenic adjuvants, and their multi-type of composite adjuvant materials studies are increasing, aiming at providing a theoretical basis for developing feasible and effective adjuvants for oral vaccines. With increasing studies related to vaccine adjuvants, strategic initiative are also happening in the market. For instance, In August 2023, Bimervax, the COVID-19 vaccine developed by the HIPRA Human Health, received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA). Bimervax is part of the SARS-CoV-2 virus spike protein combined with an adjuvant acting as an additional ingredient designed to trigger a strong immune response. It can also be administered as a booster shot in the upper arm, particularly for those aged 16 years and over. Such approvals for vaccine adjuvants is likely to favor the market growth from 2020 to 2030.

Vaccine Adjuvants Market Report Segmentation Analysis

Key segments that contributed to the derivation of the vaccine adjuvants market analysis are adjuvant class and type.

  • Based on adjuvant class, the vaccine adjuvants market is divided into mineral salt adjuvant, emulsion adjuvant, liposome adjuvant, and others. The mineral salt adjuvant segment held a larger market share in 2022.
  • By type, the market is bifurcated into human vaccine adjuvant and veterinary vaccine adjuvant. The human vaccine adjuvant segment held the largest share of the market in 2022.

Vaccine Adjuvants Market Share Analysis by Geography

The geographic scope of the Vaccine Adjuvants market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the market and Asia Pacific is anticipated to grow with the highest CAGR in the coming years. Rising infectious disease and pandemics contribute to accelerating vaccine adjuvant production in Asia Pacific, influencing market growth during 2022-2030. In India, there is high support from the National Institute of Health (NIH), which contributes to the production of vaccines. One such example is the adjuvant developed by NIH funding to enhance the efficacy of India's COVAXIN Alhydroxiquim-II vaccine. The adjuvant used in COVAXIN, named “Alhydroxiquim-II”, was discovered and tested in the laboratory by ViroVax LLC, by incorporating a small molecule attached to “Alhydrogel”, a substance commonly known as alum standing as the most common adjuvant used in the vaccines for people.

Vaccine Adjuvants Market Report Scope

Vaccine Adjuvants Market News and Recent Developments

The vaccine adjuvants market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the vaccine adjuvants market are listed below:

  • SPI Pharma Inc and Q-Vant Biosciences Inc partnered to combines Q-Vant's leadership in sustainable saponin extraction technology with SPI's global reach and servicing expertise in the pharmaceutical industry. This includes investment in expanding Q-Vant’s proprietary 100% sustainable Q-SAP technology and an exclusive commercial agreement to accelerate the global adoption of their saponin adjuvants for veterinary and human vaccine formulations. (Source: SPI Pharma Inc, Press Release, October 2023)
  • Seppic launched MONTANIDE GEL P PR, an aqueous adjuvant based on a polymeric technology dedicated to avian injectable vaccines, meeting the need for innocuity in the avian market. In addition, MONTANIDE GEL P PR is particularly stable and can resist destabilising antigenic media frequently used in avian vaccines. (Source: Seppic, Press Release, May 2024)

Vaccine Adjuvants Market Report Coverage and Deliverables

The “Vaccine Adjuvants Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

  • Vaccine adjuvants market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Vaccine adjuvants market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Vaccine adjuvants market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments3
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Vaccine Adjuvants market
  • Detailed company profiles
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Adjuvant Class, Type, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions

What is the expected CAGR of the vaccine adjuvants market?

The market is expected to register a CAGR of 14.0% during 2023–2031

What would be the estimated value of the vaccine adjuvants market by 2031?

The vaccine adjuvants market size is projected to reach US$ 7.96 billion by 2031.

What are the future trends of the vaccine adjuvants market?

Technological advancements is likely to remain key trends in the market

What are the driving factors impacting the vaccine adjuvants market?

Advantageous and product approvals of veterinary vaccine adjuvants are the key driving factors behind the market development.

Which region dominated the vaccine adjuvants market in 2023?

North America has dominated the vaccine adjuvants market

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Vaccine Adjuvants Market Landscape

4.1 PEST Analysis

5. Vaccine Adjuvants Market – Key Market Dynamics

5.1 Vaccine Adjuvants Market – Key Market Dynamics

5.2 Market Drivers

5.2.1 Rising Number of Infectious Disease Outbreaks and Pandemic

5.2.2 Approvals of Veterinary Vaccine Adjuvants

5.3 Market Restraints

5.3.1 Product Recalls and Adverse Effects

5.4 Market Opportunity

5.4.1 Support for Developments in Adjuvant Studies and Collaborative Efforts for Product Launches

5.5 Future Trends

5.5.1 Technological Advancements

5.6 Impact of Drivers and Restraints:

6. Vaccine Adjuvants Market – Global Market Analysis

6.1 Vaccine Adjuvants Market Revenue (US$ Million), 2022–2030

6.1.1 Overview

6.2 Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

7. Vaccine Adjuvants Market Analysis – by Adjuvant Class

7.1 Overview

7.2 Mineral Salt Adjuvant

7.2.1 Overview

7.2.2 Mineral Salt Adjuvant: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

7.3 Emulsion Adjuvant

7.3.1 Overview

7.3.2 Emulsion Adjuvant: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

7.4 Liposome Adjuvant

7.4.1 Overview

7.4.2 Liposome Adjuvant: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8. Vaccine Adjuvants Market Analysis – by Type

8.1 Human Vaccine Adjuvant

8.1.1 Overview

8.1.2 Human Vaccine Adjuvant: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Veterinary Vaccine Adjuvant

8.2.1 Overview

8.2.2 Veterinary Vaccine Adjuvant: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9. Vaccine Adjuvants Market – Geographical Analysis

9.1 North America

9.1.1 North America Vaccine Adjuvants Market Overview

9.1.2 North America: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.1.2.1 North America: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Adjuvant Class

9.1.2.2 North America: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Type

9.1.3 North America: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Country

9.1.3.1 United States: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.1.1 Overview

9.1.3.1.2 United States: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.1.3 United States: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.1.3.1.4 United States: Vaccine Adjuvants Market Breakdown, by Type

9.1.3.2 Canada: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.2.1 Overview

9.1.3.2.2 Canada: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.2.3 Canada: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.1.3.2.4 Canada: Vaccine Adjuvants Market Breakdown, by Type

9.1.3.3 Mexico: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.3.1 Overview

9.1.3.3.2 Mexico: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.1.3.3.3 Mexico: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.1.3.3.4 Mexico: Vaccine Adjuvants Market Breakdown, by Type

9.2 Europe

9.2.1 Europe Vaccine Adjuvants Market Overview

9.2.2 Europe: Vaccine Adjuvants Market Revenue and Forecast to 2030 (US$ Million)

9.2.2.1 Europe: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Adjuvant Class

9.2.2.2 Europe: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Type

9.2.3 Europe: Vaccine Adjuvants Market

9.2.3.1 Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.1.1 Overview

9.2.3.1.2 Germany: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.1.3 Germany: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.2.3.1.4 Germany: Vaccine Adjuvants Market Breakdown, by Type

9.2.3.2 United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.2.1 Overview

9.2.3.2.2 United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.2.3 United Kingdom: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.2.3.2.4 United Kingdom: Vaccine Adjuvants Market Breakdown, by Type

9.2.3.3 France: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.3.1 Overview

9.2.3.3.2 France: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.3.3 France: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.2.3.3.4 France: Vaccine Adjuvants Market Breakdown, by Type

9.2.3.4 Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.4.1 Overview

9.2.3.4.2 Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.4.3 Italy: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.2.3.4.4 Italy: Vaccine Adjuvants Market Breakdown, by Type

9.2.3.5 Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.5.1 Overview

9.2.3.5.2 Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.5.3 Spain: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.2.3.5.4 Spain: Vaccine Adjuvants Market Breakdown, by Type

9.2.3.6 Rest of Europe: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.6.1 Overview

9.2.3.6.2 Rest of Europe: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.2.3.6.3 Rest of Europe: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.2.3.6.4 Rest of Europe: Vaccine Adjuvants Market Breakdown, by Type

9.3 Asia Pacific

9.3.1 Asia Pacific Vaccine Adjuvants Market Overview

9.3.2 Asia Pacific: Vaccine Adjuvants Market

9.3.2.1 Asia Pacific: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Adjuvant Class

9.3.3 Asia Pacific: Vaccine Adjuvants Market

9.3.3.1 Asia Pacific: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Type

9.3.4 Asia Pacific: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Country

9.3.4.1 China: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.1.1 Overview

9.3.4.1.2 China: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.1.3 China: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.3.4.1.4 China: Vaccine Adjuvants Market Breakdown, by Type

9.3.4.2 Japan: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.2.1 Overview

9.3.4.2.2 Japan: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.2.3 Japan: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.3.4.2.4 Japan: Vaccine Adjuvants Market Breakdown, by Type

9.3.4.3 India: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.3.1 Overview

9.3.4.3.2 India: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.3.3 India: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.3.4.3.4 India: Vaccine Adjuvants Market Breakdown, by Type

9.3.4.4 Australia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.4.1 Overview

9.3.4.4.2 Australia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.4.3 Australia: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.3.4.4.4 Australia: Vaccine Adjuvants Market Breakdown, by Type

9.3.4.5 South Korea: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.5.1 Overview

9.3.4.5.2 South Korea: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.5.3 South Korea: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.3.4.5.4 South Korea: Vaccine Adjuvants Market Breakdown, by Type

9.3.4.6 Rest of APAC: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.6.1 Overview

9.3.4.6.2 Rest of APAC: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.3.4.6.3 Rest of APAC: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.3.4.6.4 Rest of APAC: Vaccine Adjuvants Market Breakdown, by Type

9.4 Middle East and Africa

9.4.1 Middle East and Africa Vaccine Adjuvants Market Overview

9.4.2 Middle East and Africa: Vaccine Adjuvants Market

9.4.2.1 Middle East and Africa: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Adjuvant Class

9.4.2.2 Middle East and Africa: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Type

9.4.3 Middle East and Africa: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Country

9.4.3.1 Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.1.1 Overview

9.4.3.1.2 Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.1.3 Saudi Arabia: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.4.3.1.4 Saudi Arabia: Vaccine Adjuvants Market Breakdown, by Type

9.4.3.2 South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.2.1 Overview

9.4.3.2.2 South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.2.3 South Africa: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.4.3.2.4 South Africa: Vaccine Adjuvants Market Breakdown, by Type

9.4.3.3 United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.3.1 Overview

9.4.3.3.2 United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.3.3 United Arab Emirates: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.4.3.3.4 United Arab Emirates: Vaccine Adjuvants Market Breakdown, by Type

9.4.3.4 Rest of Middle East and Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.4.1 Overview

9.4.3.4.2 Rest of Middle East and Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.4.3.4.3 Rest of Middle East and Africa: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.4.3.4.4 Rest of Middle East and Africa: Vaccine Adjuvants Market Breakdown, by Type

9.5 South and Central America

9.5.1 South and Central America Vaccine Adjuvants Market Overview

9.5.2 South and Central America: Vaccine Adjuvants Market

9.5.2.1 South and Central America: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Adjuvant Class

9.5.3 South and Central America: Vaccine Adjuvants Market

9.5.3.1 South and Central America: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Type

9.5.4 South and Central America: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Country

9.5.4.1 Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.5.4.1.1 Overview

9.5.4.1.2 Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.5.4.1.3 Brazil: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.5.4.1.4 Brazil: Vaccine Adjuvants Market Breakdown, by Type

9.5.4.2 Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.5.4.2.1 Overview

9.5.4.2.2 Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.5.4.2.3 Argentina: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.5.4.2.4 Argentina: Vaccine Adjuvants Market Breakdown, by Type

9.5.4.3 Rest of South and Central America: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.5.4.3.1 Overview

9.5.4.3.2 Rest of South and Central America: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

9.5.4.3.3 Rest of South and Central America: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

9.5.4.3.4 Rest of South and Central America: Vaccine Adjuvants Market Breakdown, by Type

10. Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Global Vaccine Adjuvants Market

10.3 Organic Developments

10.3.1 Overview

10.4 Inorganic Developments

10.4.1 Overview

11. Company Profiles

11.1 SPI Pharma Inc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 GSK Plc

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 THREATS

11.2.7 Key Developments

11.3 CSL Ltd

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Seppic SA

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Hawaii Biotech Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Dynavax Technologies Corp

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 InvivoGen SAS

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Croda International Plc

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Novavax Inc

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Phibro Animal Health Corp

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.1 Glossary of Terms

List of Tables

Table 1. Vaccine Adjuvants Market Segmentation

Table 2. North America: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 3. North America: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 4. United States: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 5. United States: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 6. Canada: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 7. Canada: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 8. Mexico: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 9. Mexico: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 10. Europe: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 11. Europe: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 12. Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 13. Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 14. United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 15. United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 16. France: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 17. France: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 18. Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 19. Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 20. Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 21. Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 22. Rest of Europe: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 23. Rest of Europe: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 24. Asia Pacific: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 25. Asia Pacific: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 26. China: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 27. China: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 28. Japan: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 29. Japan: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 30. India: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 31. India: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 32. Australia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 33. Australia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 34. South Korea: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 35. South Korea: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 36. Rest of APAC: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 37. Rest of APAC: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 38. Middle East and Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 39. Middle East and Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 40. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 41. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 42. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 43. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 44. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 45. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 46. Rest of Middle East and Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 47. Rest of Middle East and Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 48. South and Central America: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 49. South and Central America: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 50. Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 51. Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 52. Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 53. Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 54. Rest of South and Central America: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 55. Rest of South and Central America: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 56. Organic Developments Done by Companies

Table 57. Inorganic Developments Done by Companies

Table 58. Glossary of Terms, Vaccine Adjuvants Market

List of Figures

Figure 1. Vaccine Adjuvants Market Segmentation, by Geography

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Vaccine Adjuvants Market Revenue (US$ Million), 2022–2030

Figure 5. Vaccines Adjuvants Market, By Geography Forecast Analysis, 2022 & 2030

Figure 6. Vaccine Adjuvants Market Share (%) – by Adjuvant Class (2022 and 2030)

Figure 7. Mineral Salt Adjuvant: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8. Emulsion Adjuvant: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9. Liposome Adjuvant: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11. Vaccine Adjuvants Market Share (%) – by Type (2022 and 2030)

Figure 12. Human Vaccine Adjuvant: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13. Veterinary Vaccine Adjuvant: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14. North America: Vaccine Adjuvants Market by Key Countries – Revenue (2022) US$ Million

Figure 15. North America Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16. North America: Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 17. United States: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 18. Canada: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 19. Mexico: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 20. Europe: Vaccine Adjuvants Market – Revenue by Key Countries Revenue 2022 (US$ Million)

Figure 21. Europe Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22. Europe: Vaccine Adjuvants Market (2022 and 2030)

Figure 23. Germany: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 24. United Kingdom: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 25. France: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 26. Italy: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 27. Spain: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 28. Rest of Europe: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 29. Asia Pacific: Vaccine Adjuvants Market – Revenue by Key Countries 2022 (US$ Million)

Figure 30. Asia Pacific: Vaccine Adjuvants Market Revenue and Forecast to 2030 (US$ Mn)

Figure 31. Asia Pacific: Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 32. China: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 33. Japan: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 34. India: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 35. Australia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 36. South Korea: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 37. Rest of APAC: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 38. Middle East and Africa: Vaccine Adjuvants Market by Key Countries – Revenue 2022 (US$ Million)

Figure 39. Middle East and Africa: Vaccine Adjuvants Market Revenue and Forecast to 2030 (US$ Million)

Figure 40. Middle East and Africa: Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 41. Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 42. South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 43. United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 44. Rest of Middle East and Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 45. South and Central America: Vaccine Adjuvants Market by Key Countries – Revenue 2022 (US$ Million)

Figure 46. South and Central America: Vaccine Adjuvants Market, Revenue and Forecast to 2030 (US$ Million)

Figure 47. South and Central America: Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 48. Brazil: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 49. Argentina: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 50. Rest of South and Central America: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 51. Growth Strategies in the Global Vaccine Adjuvants Market

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..